Philip Breitfeld

Track

Insider profile

Currently holds a position at Champions Oncology Inc

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Strategic and Innovation Officer, Director Champions Oncology Inc Dec. 1, 2016 -
Director Champions Oncology Inc April 11, 2016 - Dec. 1, 2016
Philip Breitfeld's trades of Champions Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
178.88
Quantity 23,128 -29.1%
Value US$4,293,669
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-17 2020-12-16
S Sale
23,128 -29.1%
178.88
US$4,293,669 		23,128 -29.1% 178.88 US$4,293,669